Miroma Project Factory's Avow App Leads the Way in Tech-Driven Domestic Violence Prevention
SYDNEY, Nov. 5, 2025 /PRNewswire/ -- Miroma Project Factory (MPF) has re-launched an updated and re-designed version of Avow, Australia's first digital tool designed specifically to support individuals who use violence, helping them understand...
LANZAJET ANNOUNCES SELECTION OF FLUOR CORPORATION FOR FRONT-END ENGINEERING AND DESIGN (FEED) FOR PROJECT SPEEDBIRD - LANZAJET'S FLAGSHIP UK SAF PLANT
CHICAGO, Nov. 4, 2025 /PRNewswire/ -- LanzaJet, Inc., a leading next-gen fuels technology company and producer of sustainable fuels, has recently awarded the Front-End Engineering and Design (FEED) for Project Speedbird to Fluor Corporation (NYSE:...
Japan's Flying Sports Car "STAR WALKERS," Developed by World Scan Project Corporation, Takes off -- Reservations Open October 16
- Made-in-Japan Marvel, with Compact, Van-sized Design, Turned Heads at Unveiling Event, Redefining Future of Mobility and Design - TOKYO, Nov. 4, 2025 /PRNewswire/ -- World Scan Project Corporation (hereafter "WSP"), a subsidiary of World Scan...
CARsgen Announces Positive Clinical Data for Allogeneic CAR-T Products CT0596 and CT1190B
SHANGHAI, Nov. 3, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces clinical data for CT0596, an allogeneic BCMA-targeting CAR-T product...
TCT 2025 | Robot-Assisted PCI Enters a New Era: Results of the PANVIS STAR Multicenter Randomized Controlled Trial
SHANGHAI, Nov. 3, 2025 /PRNewswire/ -- The 37th Annual Transcatheter Cardiovascular Therapeutics (TCT2025) symposium was held grandly in San Francisco, USA, attracting widespread attention from the global cardiovascular community. On the morning of...
GC Biopharma's Recombinant Anthrax Vaccine, BARYTHRAX, Demonstrates Safety and Immunogenicity in Phase 2 Data, Published in 'Vaccine'
YONGIN, South Korea, Nov. 3, 2025 /PRNewswire/ -- GC Biopharma, a leading global pharmaceutical company based in South Korea, announced today that the Phase 2 clinical trial results for its anthrax vaccine 'BARYTHRAX inj. (GC1109)' have been...
AI Semiconductor Innovator DEEPX Recognized by NYSE and WEF
The Leading Player in On-Device AI Is Realizing the Physical AI Era While Drawing Wall Street's Attention NEW YORK, Oct. 31, 2025 /PRNewswire/ -- As AI begins to sustainably generate tangible value, global AI semiconductor innovator DEEPX (CEO...
Pioneering Nuclear Fusion Energy Innovation for Two Decades: Shanghai Electric Empowers Global CRAFT and ITER Projects, Driving a Sustainable Future for Earth
China's Leading High-End Equipment Manufacturer Advances International Cooperation in Nuclear Fusion Energy SHANGHAI, Oct. 31, 2025 /PRNewswire/ -- Shanghai Electric (SEHK: 2727, SSE: 601727) has recently announced several key milestones in the...
Ascletis Selects a Best-in-Class Once-Monthly Subcutaneously Administered Amylin Receptor Agonist, ASC36, for Clinical Development
-In head-to-head non-human primate (NHP) studies, average observed half-life of ASC36 was approximately 15 days, 3 -fold longer than petrelintide, which supports once-monthly subcutaneous (SQ) dosing in humans. -ASC36 demonstrated approximately 91 %...
Xinhua Silk Road: Historic city Quanzhou revitalizes heritage for new opportunities
BEIJING, Oct. 28, 2025 /PRNewswire/ -- Quanzhou, a port city in southeast China's Fujian Province, is renowned for its long history and rich culture. As the city enhances efforts to protect its cultural heritages, it is also taking measures to...